Jean-Pierre Lebrun

Oralance Pharma SA designs and develops oral forms of drug molecules. The company focuses on the development of new oral drug delivery systems protected by worldwide patents and providing API's stabilisation, gastroprotection, gastroresistance, taste masking and enhanced bioavailability. Oralance Pharma was founded in 2003 and is headquartered in Paris, France.

Oralance Pharma SA designs and develops oral forms of drug molecules. The company focuses on the development of new oral drug delivery systems protected by worldwide patents and providing API's stabilisation, gastroprotection, gastroresistance, taste masking and enhanced bioavailability. Oralance Pharma was founded in 2003 and is headquartered in Paris, France.